ArticleCell transplantation

Persistent Cytopenia After CD19 CAR T Therapy in Relapsed/Refractory DLBCL Patients Could Be a Predictor of Efficacy and Side Effects.

Jingyi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.